We highlight that week-on-week short interests for Wuxi Biologics (2269 HK) and Wuxi Apptec (2359 HK) are going in opposite directions despite both being in the Health Care sector and in CRO business.
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.